Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00205270 · ClinicalTrials.gov registry record
Influenza Vaccine in Lung Transplant Patients
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 126
- Enrollment target
NCT00205270: Completed study, sponsored by University of Wisconsin, Madison.
NCT00205270 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00205270 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
This 5-year study was designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals.
Interventions
- DRUG Influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-07 |
What the finished NCT00205270 record still lists
NCT00205270 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Influenza vaccine is the first listed.
NCT00205270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00205270 about?
NCT00205270 is a clinical study titled "Influenza Vaccine in Lung Transplant Patients". This 5-year study was designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals.
What is the current status of trial NCT00205270?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2004-12. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00205270?
The interventions under investigation include: Influenza vaccine (DRUG).
Who is sponsoring clinical trial NCT00205270?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia